These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 12055834)

  • 21. Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.
    Castro Gomes CM; Sousa MGT; Menezes JPB; Batista MC; Lima ACS; Belda W; Bradshaw D; Gama MEA; Laurenti MD; Silveira FT; Corbett CEP
    Parasitol Res; 2017 May; 116(5):1423-1431. PubMed ID: 28224222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A vaccine composed of a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection.
    Duarte MC; Lage DP; Martins VT; Costa LE; Carvalho AMRS; Ludolf F; Santos TTO; Vale DL; Roatt BM; Menezes-Souza D; Fernandes AP; Tavares CAP; Coelho EAF
    Immunobiology; 2017 Feb; 222(2):251-260. PubMed ID: 27693018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IFN-γ Response Is Associated to Time Exposure Among Asymptomatic Immune Responders That Visited American Tegumentary Leishmaniasis Endemic Areas in Peru.
    Best I; Privat-Maldonado A; Cruz M; Zimic M; Bras-Gonçalves R; Lemesre JL; Arévalo J
    Front Cell Infect Microbiol; 2018; 8():289. PubMed ID: 30186774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunity to Lutzomyia whitmani Saliva Protects against Experimental Leishmania braziliensis Infection.
    Gomes R; Cavalcanti K; Teixeira C; Carvalho AM; Mattos PS; Cristal JR; Muniz AC; Miranda JC; de Oliveira CI; Barral A
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005078. PubMed ID: 27812113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory T-Cell Dynamics in Cutaneous and Mucocutaneous Leishmaniasis due to
    Barros N; Vasquez N; Woll F; Sanchez C; Valencia B; Llanos-Cuentas A; White AC; Montes M
    Am J Trop Med Hyg; 2018 Mar; 98(3):753-758. PubMed ID: 29405108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunopathology of American cutaneous leishmaniasis.
    Pirmez C
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 5():105-9. PubMed ID: 1342704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis.
    Da-Cruz AM; Conceição-Silva F; Bertho AL; Coutinho SG
    Infect Immun; 1994 Jun; 62(6):2614-8. PubMed ID: 7910596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD3
    Ferraz R; Cunha CF; Pimentel MIF; Lyra MR; Pereira-Da-Silva T; Schubach AO; Da-Cruz AM; Bertho AL
    Parasit Vectors; 2017 May; 10(1):219. PubMed ID: 28468680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of PCR in diagnosis of human american tegumentary leishmaniasis in Rio de Janeiro, Brazil.
    Pirmez C; da Silva Trajano V; Paes-Oliveira Neto M; da-Cruz AM; Gonçalves-da-Costa SC; Catanho M; Degrave W; Fernandes O
    J Clin Microbiol; 1999 Jun; 37(6):1819-23. PubMed ID: 10325330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence of parasite DNA in clinically unaffected nasal mucosa during cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.
    Canário A; Queiroz M; Cunha G; Cavalcante T; Riesz V; Sharma R; de Noronha A; Correia T; Barral-Netto M; Barral A; Khouri R; Boaventura V
    Clin Microbiol Infect; 2019 Apr; 25(4):515.e5-515.e7. PubMed ID: 30616010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of Leishmania braziliensis antigen-specific CD4+ T, CD8+ T, NK and CD3+CD56+NKT cells in the immunopathogenesis of cutaneous leishmaniasis patients: Cytotoxic, activation and exhaustion profiles.
    Cunha CF; Ferraz-Nogueira R; Costa VFA; Pimentel MIF; Chometon TQ; Lyra MR; Schubach AO; Da-Cruz AM; Bertho AL
    PLoS One; 2020; 15(3):e0229400. PubMed ID: 32203546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4
    Moura DM; Carvalho AMRS; Brito RCF; Roatt BM; Lage DP; Martins VT; Cruz LDR; Medeiros FAC; Batista SD; Pinheiro GRG; da Costa Rocha MO; Coelho EAF; Duarte MC; Mendes TAO; Menezes-Souza D
    Vaccine; 2024 Aug; 42(21):126178. PubMed ID: 39096765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamics of American tegumentary leishmaniasis in a highly endemic region for Leishmania (Viannia) braziliensis infection in northeast Brazil.
    Silva J; Queiroz A; Moura I; Sousa RS; Guimarães LH; Machado PRL; Lessa M; Lago E; Wilson ME; Schriefer A
    PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006015. PubMed ID: 29095818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of real-time PCR assays for evaluation of immune response and parasite load in golden hamster (Mesocricetus auratus) infected by Leishmania (Viannia) braziliensis.
    Ribeiro-Romão RP; Saavedra AF; Da-Cruz AM; Pinto EF; Moreira OC
    Parasit Vectors; 2016 Jun; 9(1):361. PubMed ID: 27350537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Species diversity causing human cutaneous leishmaniasis in Rio Branco, state of Acre, Brazil.
    Tojal da Silva AC; Cupolillo E; Volpini AC; Almeida R; Romero GA
    Trop Med Int Health; 2006 Sep; 11(9):1388-98. PubMed ID: 16930261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of Leishmania braziliensis in human paraffin-embedded tissues from Tucumán, Argentina by polymerase chain reaction.
    Lanús EC; Piñero JE; González AC; Valladares B; de Grosso ML; Salomón OD
    Mem Inst Oswaldo Cruz; 2005 Apr; 100(2):187-92. PubMed ID: 16021307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection.
    Cardoso TM; Machado Á; Costa DL; Carvalho LP; Queiroz A; Machado P; Scott P; Carvalho EM; Bacellar O
    Infect Immun; 2015 Mar; 83(3):898-906. PubMed ID: 25534940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunologic Markers of Protection in Leishmania (Viannia) braziliensis Infection: A 5-Year Cohort Study.
    Muniz AC; Bacellar O; Lago EL; Carvalho AM; Carneiro PP; Guimarães LH; Rocha PN; Carvalho LP; Glesby M; Carvalho EM
    J Infect Dis; 2016 Aug; 214(4):570-6. PubMed ID: 27190181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of human T lymphocyte-mediated immune responses induced by a vaccine against American tegumentary leishmaniasis.
    Mendonca SC; De Luca PM; Mayrink W; Restom TG; Conceicao-Silva F; Da-Cruz AM; Bertho AL; Da Costa CA; Genaro O; Toledo VP
    Am J Trop Med Hyg; 1995 Aug; 53(2):195-201. PubMed ID: 7677224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular immune response profile in patients with American tegumentary leishmaniasis prior and post chemotherapy treatment.
    Reis LC; Brito ME; Souza MA; Medeiros AC; Silva CJ; Luna CF; Pereira VR
    J Clin Lab Anal; 2009; 23(1):63-9. PubMed ID: 19140214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.